GME Stock Recent News
GME LATEST HEADLINES
GRAPEVINE, Texas--(BUSINESS WIRE)--GameStop Corp. (NYSE: GME) (“GameStop” or the “Company”) today announced that it will report second quarter fiscal 2025 results after the market closes on Tuesday, September 9, 2025.
GameStop (GME) closed the most recent trading day at $22.36, moving 1.43% from the previous trading session.
GameStop (GME) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
GameStop's strong cash reserves and low leverage provide downside protection and flexibility for strategic growth, supporting my Buy rating with a $30 price target. Management is effectively pivoting from declining legacy retail to high-margin trading cards and collectibles, highlighted by a key PSA partnership and robust segment growth. Despite a premium P/E, GameStop's turnaround is evident in surging profitability and working capital, with continued cost cuts and a successful rebranding underway.
GameStop (GME) closed at $22.82 in the latest trading session, marking a -1.25% move from the prior day.
UnitedHealth Group UNH stock is soaring Friday morning with a handful of large investors revealing long positions in the health insurance company via quarterly 13F filings.
GME's core business is shrinking and management shows little interest in revitalizing it, focusing instead on raising cash and new ventures. I expect a significant investment or acquisition announcement soon. Rising short interest and poor sentiment set the stage for a potential short squeeze, making GME attractive for speculative positioning.
Citron Research founder and famed short seller Andrew Left announced a new short pick on Wednesday during an appearance on Fox Business.
In the latest trading session, GameStop (GME) closed at $22.93, marking a +2.32% move from the previous day.
GameStop (GME) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.